Company intelligence / Profile preview

Neuroelectrics Barcelona

Barcelona, Catalonia, Spain

Ownership: Private
Employees: ~44
Development stage: Other

Overview

Positive clinical trial results in medication-resistant epilepsy using Starstim: Of 17 patients, treatment resulted in reduced seizure frequency and severity. Pilot studies in depression demonstrated feasibility of at-home neuromodulation. Clinical pipeline includes pivotal trial in refractory focal epilepsy and pilot for depression.

Therapeutic areas: NeurologyPsychiatry
Modalities: DeviceNon-pharmacological therapyNeuromodulation (Transcranial Electrical Stimulation)EEG-based therapy
Industry: Therapeutic Medical Devices

Partnerships

Clinical and research partnerships with academic centers and neuroscience institutionsHealth Canada approvalCE mark collaborations

Beyond the preview

Go deeper on Neuroelectrics Barcelona.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroelectrics Barcelona.

Explore the full profile